|
|
| Attention Investors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Your results on : IPO | IPO Synopsis |
|
|
|
| Suraksha Diagnostic Ltd |
|
Registered Office:
Plot No DG-12/1 Action Area 1D,Premieses No 02-0327 Rajarhat
,
Kolkata
-
700156
,
West Bengal
, India.
Phone :
+91 33 6605 9750 Fax:
Email : investors@surakshanet.com
Website : www.surakshanet.com
|
Initial public offering of 19,189,330 equity shares of face value of  2 each of Suraksha Diagnostic Limited (the "Company" or the "Issuer") for cash at a price of 441 per equity share (including a premium of 439 per equity share) (the "Offer Price") aggregating to 846.25 crores through an offer for sale of 19,189,330 equity shares of face value of 2 each aggregating to 846.25 crores, comprising 2,132,148 equity shares of face value of 2 each aggregating to 94.03 crores by Somnath Chatterjee, 2,132,148 equity shares of face value of 2 each aggregating to 94.03 crores by Ritu Mittal, 2,132,148 equity shares of face value of 2 each aggregating to 94.03 crores by Satish Kumar Verma (whose shares are jointly held with Suman Verma) (together with Somnath Chatterjee and Ritu Mittal, the "Promoter Selling Shareholders"), 10,660,737 equity shares of face value of 2 each aggregating to 470.14 crores by Orbimed Asia ii Mauritius Limited^ (the "Investor Selling Shareholder"), 799,556 equity shares of face value of 2 each aggregating to 35.26 cores by Munna Lal Kejriwal, and 1,332,593 equity shares of face value of 2 each aggregating to 58.77 crores by Santosh Kumar Kejriwal (together the "Individual Selling Shareholders") (the promoter selling shareholders, the investor selling shareholder and the individual selling shareholders, collectively referred to as the "Selling Shareholders", and such equity shares offered by the selling shareholders, the "Offered Shares") (the "Offer" or the "Offer for Sale"). The offer constitutes 36.84% of the post-offer paid-up equity share capital of the company.
^ Surviving entity pursuant to amalgamation of orbimed Asia ii Mauritius fdi investments limited, the erstwhile shareholder, into orbimed asia ii mauritius limited on november 11, 2022
The face value of the equity shares is 2 each and the offer price is 220.5 times the face value of the equity shares.
|
| Issue |
Money Payable On |
|
| Opens On |
Closes On |
Application |
Allotment |
|
| 29-Nov-24 |
03-Dec-24 |
Rs441.00-0.00 |
Rs0.00-0.00 |
| Minimum Application for shares in Nos :34 Further Multiples of :34 |
| |
RsCr |
Lead Managers to the Issue |
|
| Project Cost |
0.00 |
|
| Project Financed through Current Offer |
846.25 |
|
| Post Issue Equity Share Capital |
14.25 |
|
| Issue Price |
Rs441.00 |
|
|
|
|
| |
| Projects |
|
| Listing the Equity Shares on the Stock Exchanges | |
|
|
|
| Promoted By |
|
| Somnath Chatterjee |
| Ritu Mittal |
| Satish Kumar Verma |
|
|
| Registrar to the Issue |
|
| KFin Techologies Ltd |
|
|
| |
|
|
|
|
|
| |
|
|
| |
| X |
| Filing complaints on SCORES |
| Easy & Quick |
| |
| › |
Register on SCORES Portal |
› |
Mandatory details for filing complaints on SCORES
| Name |
PAN |
Address |
Mobile No. |
Email ID |
|
| › |
Benefits: |
| |
|
|
|